Inactive Instrument
4SC AG Stock London S.E.
Stocks
0R6U
DE000A3E5C40
Biotechnology & Medical Research
Last Transcript: 4SC AG
| 17/10/25 | 4SC : Quarterly Report Q3 2025 Conference Call | PU |
| 17/10/25 | 4SC : Q3 Announcement 2025 | PU |
| 17/04/25 | 4SC : Q1 Announcement 2025 | PU |
| 17/10/24 | 4SC : publishes Q3 2024 report | PU |
| 17/10/24 | 4SC : Q3 Announcement 2024 | PU |
| 1 day | -36.64% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Operating Officer | - | 14/11/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Manfred Rüdiger
BRD | Director/Board Member | 61 | 16/08/2005 |
| Chairman | 66 | 19/09/2014 | |
Helmut Jeggle
BRD | Director/Board Member | 55 | 05/06/2008 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -36.64% | -52.50% | - | - | 1.28M | |
| +1.44% | -1.25% | +64.25% | +114.23% | 55.19B | |
| +4.60% | +3.02% | +57.38% | +48.98% | 45.75B | |
| -1.44% | +0.39% | -14.68% | -17.33% | 22.98B | |
| -2.69% | -2.10% | -6.70% | +374.02% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -20.46% | 16.26B | |
| +0.58% | +1.08% | +18.85% | -37.32% | 15.42B | |
| -1.01% | -2.30% | +28.59% | +174.08% | 13.05B | |
| +4.95% | +11.70% | +125.78% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.05% | - | 12.37B | |
| Average | -2.39% | +2.23% | +36.71% | +111.05% | 23.8B | |
| Weighted average by Cap. | +1.63% | +1.48% | +40.78% | +101.14% |
Employees
14
